What Uncancer does

Uncancer LLC designs and sells oral care and adaptive apparel products for people undergoing cancer treatment. The oral care (OC) line is built on nano-Hydroxyapatite (nHAP) fluoride-free formulations intended to address chemotherapy-induced dry mouth, tooth sensitivity, mucositis, and cracked lips, and includes a Sensitive Teeth Kit, Dry Mouth Kit, Toothpaste, Soothing Mouth Rinse, Dry Mouth Candies, Lip Balm, and Remineralization Gel. The Comfort Wear (CW) line offers adaptive shirts, pants, caps, beanies, and a port-friendly Comfort Shield designed to ease treatment visits. Products are sold direct-to-consumer through a Shopify storefront at uncancer.com with optional monthly subscription kits, at price points ranging from $10 to $85 per item.

The company operates a dual go-to-market. The DTC motion is content-led, with an extensive blog, patient checklists, podcast appearances, and organic social driving traffic to the e-commerce site. The enterprise motion is delivered through OSEM (Oncology Side Effect Management), a value-based care platform housed under Reliefco that combines AI-driven claims intelligence, home delivery of preventive oral care, RN navigation, and actuarial outcome measurement for health plan and pharma partners. Enterprise economics are structured around an illustrative $220 PMPM program cost with a shared-savings component retaining 75% of documented savings for the health plan, yielding illustrative ROI of 2.0x-3.3x for high-risk oncology cohorts under multi-year contracts.

Uncancer was founded in 2020 by Dr. Abida Taher, MD, PhD and Dr. Robyn Lesser, MD, PhD, and is incorporated in New York with operating headquarters in Dunedin, Florida. The company is privately held, has 1-10 employees, and reports no external funding. Disclosed enterprise traction includes a prior national Cigna Medicare Advantage deployment that enrolled 4,022 oncology patients and a strategic collaboration with Daiichi Sankyo and AstraZeneca to support oral toxicity prevention for the Dato-DXd ADC therapy.

Name

Uncancer

Legal name

Uncancer LLC

Website

https://uncancer.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Uncancer provides doctor-formulated oral care products and adaptive apparel designed for cancer patients managing chemotherapy side effects, distributed DTC via Shopify and through OSEM value-based care partnerships with health plans and pharma companies.

Ownership category

akta.pro rank

Product category

Oncology Support Products

NAICS

Cosmetics, Beauty Supplies, and Perfume Retailers (456120), Health and Personal Care Retailers (456)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)

akta.pro primary industry

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Oncology oral care
• Adaptive chemo apparel
• Cancer symptom management
• Value-based oncology care
• Specialty dental products

Headquarters

HQ city

Dunedin

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain

Revenue model

1. Product Sales (Oral Care & Comfort Wear): Direct-to-consumer e-commerce sales of oral care products (toothpaste, mouth rinse, dry mouth candies, lip balm, remineralization gel, sensitive teeth kits, dry mouth kits) and comfort wear apparel (adaptive shirts, pants, hats, port protectors) for cancer patients. One-time purchase and subscription options available.
2. Subscription Plans: Monthly subscription model delivering oral care kits every 30 days. Customers receive invoices with checkout links for recurring orders. Kits can be customized based on patient needs.
3. Value-Based Care Partnerships (B2B): OSEM platform partnerships with health plans and pharma companies. Combines PMPM operating model with shared-savings alignment where Uncancer participates in upside only when documented cost reductions are achieved in oncology side effect management.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Uncancer sells doctor- and dentist-formulated oral care products and adaptive comfort apparel designed for people undergoing cancer treatment. The Oral Care (OC) line uses proprietary nHAP (nano-Hydroxyapatite) fluoride-free formulations to address chemo-induced dry mouth, tooth sensitivity, mucositis, and cracked lips. The Comfort Wear (CW) line provides adaptive clothing with port access and dignity features for treatment visits and everyday wear. Products are sold direct-to-consumer via a Shopify storefront with one-time purchase and monthly subscription options.

Product overview

Uncancer is a direct-to-consumer e-commerce company offering two integrated product collections — Oral Care (OC) and Comfort Wear (CW) — for cancer patients and their caregivers. The OC portfolio comprises nHAP fluoride-free oral care products (Sensitive Teeth Kit, Dry Mouth Kit, Dry Mouth Candies, Soothing Mouth Rinse, Toothpaste, Lip Balm, and Remineralization Gel) designed by doctors and dentists to address chemo-induced oral side effects. The CW portfolio consists of adaptive apparel (Adaptive Crew shirts for men and women, Comfort Shield, Flex Pant, Baseball Cap, and Cozy Beanie) engineered to ease treatment visits and accommodate medical devices. The company also operates OSEM™, a value-based care platform division serving health plans and pharma partners with claims-driven patient identification, home delivery of preventive products, RN navigation, and outcomes measurement. The broader offering includes educational blog content, stress-less checklists, and gift cards.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 4,022 oncology patients enrolled in prior Cigna Medicare Advantage deployment with strong patient-reported symptom relief and satisfaction
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature1 record

Partnerships

13 partnerships are on record, tiered core and minor.

• Cigna Medicare AdvantagecoreStrategic or Co-development PartnerPrior national payer deployment enrolled 4,022 oncology patients under OSEM value-based care model. Generated strong patient-reported symptom relief and satisfaction outcomes. Demonstrated feasibility of preventive oral care intervention at scale.
• Daiichi Sankyo + AstraZenecacoreStrategic or Co-development PartnerUncancer selected to support oral toxicity prevention for Dato-DXd, one of the highest oral-burden ADC therapies. Protocol activates at treatment initiation with no referral or prior authorization burden. Designed to protect treatment continuity.
• Pink FundminorGTM or Marketing PartnerNon-profit organization providing financial support to breast cancer patients. Partner logo displayed on Uncancer trusted partners page.
• Susan KomenminorGTM or Marketing PartnerBreast cancer organization. Partner logo displayed on Uncancer trusted partners page.
• American Cancer SocietyminorGTM or Marketing PartnerVia Side Effect Support partnership. Partner logo displayed on Uncancer trusted partners page.
• Oncology Nursing Society (ONS)minorGTM or Marketing PartnerProfessional organization for oncology nurses. Partner logo displayed on Uncancer trusted partners page.
• Oral Cancer FoundationminorGTM or Marketing PartnerNon-profit dedicated to oral cancer awareness and support. Partner logo displayed on Uncancer trusted partners page.
• SharsheretminorGTM or Marketing PartnerJewish breast cancer organization supporting women and families. Partner logo displayed on Uncancer trusted partners page.
• Twisted PinkminorGTM or Marketing PartnerBreast cancer support organization. Partner logo displayed on Uncancer trusted partners page.
• Fighting PrettyminorGTM or Marketing PartnerOrganization helping women feel fierce and beautiful during cancer treatment. Partner logo displayed on Uncancer trusted partners page.
• BRCA StrongminorGTM or Marketing PartnerBRCA mutation awareness and support organization. Partner logo displayed on Uncancer trusted partners page.
• Benco DentalminorGTM or Marketing PartnerDental distribution company. Partner logo displayed on Uncancer trusted partners page.
• Cigna HealthcarecoreStrategic or Co-development PartnerCigna Starter Kit available for Cigna members. Partnership for providing oral care solutions to oncology patients.

Scale indicators5 records

Recent moves4 records

Expansion highlights5 records

Emerging players

• Thyme Care: Thyme Care is an oncology-focused value-based care navigation company working with health plans to reduce total cost of care for cancer patients. It is an adjacent emerging player in the same payer-facing oncology support category as Uncancer's OSEM division.
• Pack Health: Pack Health is a digital health coaching company that partners with pharma and payers on condition-specific patient engagement and outcomes measurement. It overlaps with Uncancer's OSEM model in payer- and pharma-facing outcomes-driven engagement, though it does not focus on oncology oral care products.
• Carifree: Carifree is a dental-products company focused on cavity prevention and remineralization technology, with professional dental channel distribution. It overlaps with Uncancer's nHAP remineralization positioning and is a relevant emerging player in the specialty oral care space.

Broad incumbents

• Procter & Gamble (Oral-B / Crest): Procter & Gamble operates Crest and Oral-B, the leading mass-market oral care franchises with deep dental professional endorsement and clinical research infrastructure. It is the primary broad-incumbent competitor in the fluoride and sensitivity toothpaste category where Uncancer's OC Sensitive Teeth Kit competes.
• Tom's of Maine: Tom's of Maine is a Colgate-Palmolive-owned natural oral care brand selling fluoride-free toothpaste and mouth rinses through mass retail. It is a broad incumbent in the same natural-ingredient oral care category as Uncancer's OC line, though it lacks the oncology-specific positioning.
• Burt's Bees: Burt's Bees is a Clorox-owned natural personal care brand with adjacent lip balm and skincare offerings that overlap with Uncancer's OC Lip Balm and oral care portfolio. It is a broader incumbent rather than a direct oncology competitor, but competes for the same natural-ingredient-conscious buyer.
• Colgate-Palmolive: Colgate-Palmolive is the dominant global oral care incumbent with extensive R&D, retailer relationships, and clinical programs. While it does not focus on oncology-specific formulations, its scale and ability to launch condition-specific sub-brands represent the primary competitive ceiling for Uncancer's OC line.

Direct peers

• Boka: Boka is a direct-to-consumer oral care brand built around nano-hydroxyapatite (nHAP) fluoride-free formulations — the same core ingredient technology Uncancer uses. It targets mainstream consumers rather than oncology patients, but the formulation overlap, channel model, and ingredient positioning make it the closest comparable.
• Care+Wear: Care+Wear is a direct-to-consumer adaptive apparel brand designed for patients undergoing medical treatment, including port access and recovery needs. It is the most directly comparable peer to Uncancer's Comfort Wear collection, competing in the same niche.
• Hello Products: Hello is a natural-ingredient oral care brand selling toothpaste, mouth rinse, and breath products direct-to-consumer via e-commerce. It competes in the same natural, free-from positioning that Uncancer's OC line occupies, though without the oncology-specific clinical framing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/uncancer.team
• LinkedInlinkedin.com/company/uncancerteam
• Instagraminstagram.com/uncancer.team

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Uncancer